JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.R700004200 on May 14, 2007

J. Biol. Chem., Vol. 282, Issue 28, 20047-20051, July 13, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/28/20047    most recent
R700004200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pestka, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pestka, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Minireview

The Interferons: 50 Years after Their Discovery, There Is Much More to Learn*Formula

Sidney Pestka1

From the Department of Molecular Genetics, Microbiology, and Immunology, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854

The interferons (IFNs) and their receptors represent a subset of the class 2 {alpha}-helical cytokines that have been in chordates for millions of years. This brief review focuses on the discovery and purification of interferons, cloning of human IFN-{alpha} and IFN-beta, interferon receptors, activities and therapeutic uses of interferons, and the side effects of interferons.


* This minireview will be reprinted in the 2007 Minireview Compendium, which will be available in January, 2008. These studies were supported by the Roche Institute of Molecular Biology, by United States Public Health Services Grants RO1-CA46465 from the National Cancer Institute and RO1-AI36450 and RO1-AI43369 from NIAID, National Institutes of Health, and by PBL Biomedical Laboratories. This is the first article of four in the Interferon Minireview Series.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1 and Figs. 1–5.

1 To whom correspondence should be addressed. E-mail: Pestka{at}umdnj.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
J.-J. Kiladjian, B. Cassinat, S. Chevret, P. Turlure, N. Cambier, M. Roussel, S. Bellucci, B. Grandchamp, C. Chomienne, and P. Fenaux
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
Blood, October 15, 2008; 112(8): 3065 - 3072.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Bitko, A. Musiyenko, M. A. Bayfield, R. J. Maraia, and S. Barik
Cellular La Protein Shields Nonsegmented Negative-Strand RNA Viral Leader RNA from RIG-I and Enhances Virus Growth by Diverse Mechanisms
J. Virol., August 15, 2008; 82(16): 7977 - 7987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Samuel
Interferons, Interferon Receptors, Signal Transducer and Transcriptional Activators, and Interferon Regulatory Factors
J. Biol. Chem., July 13, 2007; 282(28): 20045 - 20046.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.